You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
STTR Phase I: An augmentative tool to connect speech language pathologists with patients
SBC: LISS, JULIE Topic: SHThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project addresses the issue of communicative ability in individuals with neurogenic disorders. The inability to engage in spoken communication is among the most debilitating of all human conditions. Because treatment is behavioral and intensive, access to care and quality of care are significant issue ...
STTR Phase I 2015 National Science Foundation -
STTR Phase I: Non-Invasive Through-The-Eyelid Tonometer for Frequent Eye Pressure Measurements
SBC: EPVSensors LLC Topic: SHThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be in the ability to better screen for and manage glaucoma. Americans over the age of 40 need to be screened for elevated eye pressure which may lead to glaucoma and blindness. This STTR project aims to develop a non-invasive low-cost instrument that will allow frequent eye pressure measu ...
STTR Phase I 2015 National Science Foundation -
A Low Cost, Quantitative, Chemical Specific Device for Illicit Drug Detection
SBC: MKS Technology Topic: NIDADESCRIPTION provided by applicant This proposal will assess the quantitative capabilities of surface enhanced Raman scattering SERS detection of cocaine and marijuana metabolites in urine samples Combining low cost instrumentation and novel chemical sensing provides an innovative new approach for diagnosing illicit drug use Current methods use a colorimetric indicator to screen specimens fo ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Reduced gluten cereal grains
SBC: Arcadia Biosciences, Inc. Topic: 300DESCRIPTION provided by applicant Celiac disease CD is the most common food sensitive enteropathy known affecting approximately of the population and its incidence appears to be on the rise In addition non celiac gluten sensitivity GS has recently been revealed to be a distinct condition that affects a growing number of individuals Both of these conditions are triggered by gluten a ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Synactix Pharmaceuticals I-Corps Application
SBC: SYNACTIX PHARMACEUTICALS, INC. Topic: 102DESCRIPTION provided by applicant Polypharmacology represents a new and attractive approach to treat malignances as lasting and robust efficacy could be obtained through the inhibition of multiple survival pathways with one therapeutic agent In line with this method we have designed a RET rearranged during transfection VEGFR vascular endothelial growth factor receptor small molecule ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Pre-IND study of PMT-254, a pan-FLT3 inhibitor for the treatment of FLT3 driven cancers.
SBC: PROMUTECH PHARMACEUTICALS, INC. Topic: 102DESCRIPTION provided by applicant Pathological activating mutations in the FLT kinase represent the most common genetic alteration in patients with acute myeloid leukemia AML occurring in approximately one third of cases Recently we performed translational studies that identified drug resistant kinase domain mutations in FLT ITD at the time of relapse in AML patients treated with the FLT ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Extraction and Characterization of a Safer, Cost-effective Anti-inflammatory
SBC: Botanisol LLC Topic: RDESCRIPTION provided by applicant Inflammatory disease states are leading causes of death and disability and a major cost to healthcare in the United States There is an epidemic of death and hospitalizations due to adverse effects from NSAIDs TAI LCx Turmeric Anti Inflammatory Lipophilic Component X is a novel anti inflammatory discovered in previously unrecognized pharmacologically activ ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health